Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-044600
Filing Date
2019-11-27
Accepted
2019-11-27 06:04:55
Documents
86
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20190930.htm 6-K 4044849
  Complete submission text file 0001564590-19-044600.txt   15934161

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT meso-20190930.xml EX-101.INS 4624359
3 XBRL TAXONOMY EXTENSION SCHEMA meso-20190930.xsd EX-101.SCH 101389
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meso-20190930_cal.xml EX-101.CAL 89581
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meso-20190930_def.xml EX-101.DEF 255706
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meso-20190930_lab.xml EX-101.LAB 556029
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meso-20190930_pre.xml EX-101.PRE 450645
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 191253136
SIC: 2836 Biological Products, (No Diagnostic Substances)